NCT06289530

Brief Summary

This observational study was conducted in patients undergoing elective pancreaticoduodenectomy or distal pancreatectomy. It mainly answers the following two main questions:

  1. 1.What are the risk factors for clinically relevant postoperative pancreatic fistula in different pancreatic surgeries?
  2. 2.What is the correlation between perioperative blood and interstitial fluid glucose level and clinically relevant postoperative pancreatic fistula in different pancreatic surgeries?

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
600

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Mar 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 25, 2024

Completed
5 days until next milestone

Study Start

First participant enrolled

March 1, 2024

Completed
3 days until next milestone

First Posted

Study publicly available on registry

March 4, 2024

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2025

Completed
Last Updated

December 11, 2024

Status Verified

March 1, 2024

Enrollment Period

1.1 years

First QC Date

February 25, 2024

Last Update Submit

December 6, 2024

Conditions

Keywords

clinically relevant postoperative pancreatic fistulapancreatic surgeryperioperative interstitial fluid glucose level

Outcome Measures

Primary Outcomes (1)

  • Clinically relevant postoperative pancreatic fistula

    Clinically relevant postoperative pancreatic fistula is now redefined as a drain output of any measurable volume of fluid with an amylase level \>3 times the upper limit of institutional normal serum amylase activity, associated with a clinically relevant development/condition related directly to the postoperative pancreatic fistula.

    30 days after surgery

Secondary Outcomes (5)

  • Bile leakage

    30 days after surgery

  • Chyle leak

    30 days after surgery

  • Postpancreatectomy hemorrhage

    30 days after surgery

  • Abdominal infection

    30 days after surgery

  • Delayed gastric emptying

    30 days after surgery

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Adult patients undergoing elective pancreaticoduodenectomy or distal pancreatectomy from March 2024 to October 2024.

You may qualify if:

  • Patients scheduled for elective pancreaticoduodenectomy
  • Patients scheduled for distal pancreatectomy
  • Patients scheduled for duodenum-preserving resection of pancreatic head.

You may not qualify if:

  • Patients with functional pancreatic neuroendocrine tumors.
  • Patients with previous pancreatic surgery.
  • Patients with severe pancreatitis.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Peking Union Medical College Hospital,Chinese Academy of Medical Science and Peking Union Medical College

Beijing, Beijing Municipality, 100730, China

RECRUITING

Related Publications (1)

  • Lan L, Zhang Y, Zhang L, Zhang Y, Shen L, Huang Y. Association between perioperative continuous glucose monitoring and clinically relevant postoperative pancreatic fistula (CR-POPF) in pancreatic surgery: a protocol for a prospective cohort study. BMJ Open. 2025 Jun 17;15(6):e092046. doi: 10.1136/bmjopen-2024-092046.

Study Officials

  • YuGuang Huang, MD

    Peking Union Medical College Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 25, 2024

First Posted

March 4, 2024

Study Start

March 1, 2024

Primary Completion

March 31, 2025

Study Completion

April 30, 2025

Last Updated

December 11, 2024

Record last verified: 2024-03

Data Sharing

IPD Sharing
Will not share

Locations